Immediate Impact

7 from Science/Nature 58 standout
Sub-graph 1 of 21

Citing Papers

Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia
2025 Standout
Indolent CD4+ CAR T-Cell Lymphoma after Cilta-cel CAR T-Cell Therapy
2024 Standout
2 intermediate papers

Works of Elena Hartmann being referenced

Safety and activity of ibrutinib plus rituximab for patients with high-risk chronic lymphocytic leukaemia: a single-arm, phase 2 study
2014
A distinctive subtype of t(14;18)-negative nodal follicular non-Hodgkin lymphoma characterized by a predominantly diffuse growth pattern and deletions in the chromosomal region 1p36
2008

Author Peers

Author Last Decade Papers Cites
Elena Hartmann 1446 972 663 1105 80 2.6k
Soham D. Puvvada 955 962 788 1085 56 2.5k
Evelyne Callet‐Bauchu 1719 894 536 1118 62 2.6k
Ellen Schlette 1294 692 691 1307 68 2.3k
Yasuhito Terui 802 1035 704 572 126 2.3k
Andrew R. Pettitt 1381 774 761 1673 102 2.6k
Marta Crespo 1257 603 858 1511 51 2.7k
Antonella Aiello 1015 905 1427 725 61 3.0k
Valentin Goede 1197 763 998 1340 75 3.1k
Christian H. Geisler 1724 1076 325 1197 52 2.3k
Loïc Ysebaert 1642 1459 789 1077 136 3.6k

All Works

Loading papers...

Rankless by CCL
2026